A pill to restore natural hearing moves one step closer to market as Otologic Pharmaceutics has entered into an agreement with Oblato Inc.
The sickle cell pain drug, Adakveo, was researched and created in Oklahoma City. Several entities at the Innovation District were involved in the work, including the Oklahoma Medical Research Foundation and Cytovance Biologics.
The MAPS 4 proposal includes a number of projects intended to promote community and collaboration in an area where health, energy, aerospace, technology and research companies rub elbows.
A number of MAPS 4 proposals designed to foster community and collaboration in Oklahoma City’s Innovation District have the potential to grow Oklahoma’s economic output exponentially.
For the past eight years, Brewfest has been a great place to showcase the state’s burgeoning brewery scene.
Revolutionary tumor-fighting treatment now offered.
The funding will support laboratory projects as well as clinical studies to help Oklahomans suffering from conditions such as multiple sclerosis and lupus.
The request includes four projects and an operating fund, which were outlined as economically-vital district improvements in Perkins + Will’s land use and strategic development plan which was released last week.